PL3429689T3 - Bezkomórkowe preparaty z łożyska - Google Patents

Bezkomórkowe preparaty z łożyska

Info

Publication number
PL3429689T3
PL3429689T3 PL17767314T PL17767314T PL3429689T3 PL 3429689 T3 PL3429689 T3 PL 3429689T3 PL 17767314 T PL17767314 T PL 17767314T PL 17767314 T PL17767314 T PL 17767314T PL 3429689 T3 PL3429689 T3 PL 3429689T3
Authority
PL
Poland
Prior art keywords
placental preparations
acellular
acellular placental
preparations
placental
Prior art date
Application number
PL17767314T
Other languages
English (en)
Inventor
Scott A. Washburn
Original Assignee
Plakous Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plakous Therapeutics, Inc. filed Critical Plakous Therapeutics, Inc.
Publication of PL3429689T3 publication Critical patent/PL3429689T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
PL17767314T 2016-03-14 2017-03-14 Bezkomórkowe preparaty z łożyska PL3429689T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662307629P 2016-03-14 2016-03-14
EP17767314.2A EP3429689B1 (en) 2016-03-14 2017-03-14 Acellular placental preparations
PCT/US2017/022257 WO2017160804A1 (en) 2016-03-14 2017-03-14 Acellular placental preparations

Publications (1)

Publication Number Publication Date
PL3429689T3 true PL3429689T3 (pl) 2022-03-21

Family

ID=59851853

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17767314T PL3429689T3 (pl) 2016-03-14 2017-03-14 Bezkomórkowe preparaty z łożyska

Country Status (10)

Country Link
US (1) US20200239836A1 (pl)
EP (2) EP4008400A1 (pl)
JP (2) JP7050692B2 (pl)
CN (2) CN109069867B (pl)
AU (2) AU2017235220B2 (pl)
CA (1) CA3016606A1 (pl)
DK (1) DK3429689T3 (pl)
ES (1) ES2907751T3 (pl)
PL (1) PL3429689T3 (pl)
WO (1) WO2017160804A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018144694A1 (en) 2017-02-01 2018-08-09 Plakous Therapeutics, Inc. Placental tissue compositions
US20220195382A1 (en) 2019-04-04 2022-06-23 THT Biomaterials GmbH A novel human-material-based platfom technology for tissue engineering
CA3138884A1 (en) * 2019-05-06 2020-11-12 Accelerated Biosciences Corp. Precursory regulatory cytotrophoblast cells and uses thereof
US20220401495A1 (en) * 2019-11-27 2022-12-22 Plakous Therapeutics, Inc. Acellular placental therapies for necrotizing enterocolitis
WO2022120382A1 (en) * 2020-12-03 2022-06-09 42Bio, Inc. Regenerative tissue extract from non-human mammalian placenta
CA3230944A1 (en) * 2021-09-07 2023-03-16 Scott A. Washburn Acellular placental therapies
CN114886925B (zh) * 2022-05-25 2023-10-13 兰州大学 羊胎盘提取物在制备预防或治疗癌症恶病质药物中的应用
CN116370690B (zh) * 2023-03-10 2024-08-20 广州正源生物技术有限公司 胎盘底蜕膜复合制剂、其制法，含有其的医用敷料及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8187639B2 (en) * 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
US8153162B2 (en) * 2005-09-27 2012-04-10 Tissuetech, Inc. Purified amniotic membrane compositions and methods of use
WO2008060377A2 (en) * 2006-10-04 2008-05-22 Anthrogenesis Corporation Placental or umbilical cord tissue compositions
KR101118017B1 (ko) * 2009-09-04 2012-02-24 (주)차바이오앤디오스텍 태반 추출물을 제조하는 방법 및 태반 추출물
US20110256202A1 (en) * 2010-02-18 2011-10-20 Samson Tom Immunocompatible amniotic membrane products
CN102327640A (zh) * 2011-09-29 2012-01-25 协和干细胞基因工程有限公司 一种脱细胞羊膜的制备方法
US20130218274A1 (en) * 2011-12-02 2013-08-22 Mimedx Group, Inc. Shredded tissue grafts and methods for making and using the same
CN103114073B (zh) * 2013-01-23 2014-11-05 宁波大学 一种人羊膜的脱细胞方法
CN103861151B (zh) * 2014-03-27 2016-03-30 成都青山利康药业有限公司 一种脱细胞胎盘基质材料的制备方法
WO2015171142A1 (en) 2014-05-07 2015-11-12 Osiris Therapeutics, Inc. Therapeutic placental compositions, methods of making and methods of use
JP2018516869A (ja) * 2015-05-20 2018-06-28 ティッシュテック，インク． 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法

Also Published As

Publication number Publication date
ES2907751T3 (es) 2022-04-26
AU2022204044A1 (en) 2022-06-30
WO2017160804A1 (en) 2017-09-21
EP3429689A1 (en) 2019-01-23
DK3429689T3 (da) 2022-01-31
CN109069867B (zh) 2022-02-01
AU2022204044B2 (en) 2024-03-07
JP2019508478A (ja) 2019-03-28
CN114404454A (zh) 2022-04-29
EP3429689A4 (en) 2019-11-06
CN109069867A (zh) 2018-12-21
EP3429689B1 (en) 2021-12-22
AU2017235220A1 (en) 2018-09-27
EP4008400A1 (en) 2022-06-08
US20200239836A1 (en) 2020-07-30
JP7050692B2 (ja) 2022-04-08
AU2017235220B2 (en) 2022-03-24
CA3016606A1 (en) 2017-09-21
JP2022101565A (ja) 2022-07-06

Similar Documents

Publication Publication Date Title
HK1253323A1 (zh) 免疫原性降低的crispr-相關(cas)蛋白
EP3154557A4 (en) Acellular amnion derived therapeutic compositions
PT3429644T (pt) Composição compatível com a pele
PL3429689T3 (pl) Bezkomórkowe preparaty z łożyska
SI3473263T1 (sl) Kombinirani pripravki za zdravljenje raka
SG10202107298RA (en) Hair-growth agent
HK1258583A1 (zh) 皮膚美白化妝品
GB201909518D0 (en) 4-N-Butylresorcinol preparations
HK1253244A1 (zh) 使用受刺激的胎盤幹細胞的血管生成
SG10201913501RA (en) Liposomal formulations
GB2538767B (en) Coffin
IL252955B (en) Compounds for mouthwash
GB201603474D0 (en) Hairstyling former
GB201620399D0 (en) Hair vacuum
PT3445377T (pt) Composições para a pele
HUE057047T2 (hu) Turmeronokat tartalmazó bõrkezelõ készítmények
GB201706600D0 (en) Virus preparations
AU2016313V (en) PMB012 Agapanthus orientalis
ZA201703472B (en) Mouthrinse formulations
GB201621277D0 (en) Formulations
GB201618110D0 (en) Formulations
GB201614243D0 (en) Tjti&tjtd
GB201614244D0 (en) Tjti&tjtd
GB201614173D0 (en) Tjti&tjtd
GB201616366D0 (en) Formulations